Fed. Circ. Finds Respironics' Apnea Patents Invalid
The Federal Circuit on Friday ruled that two Respironics Inc. patents for sleep apnea treatments were invalid as anticipated by prior art, reversing a lower court and handing a victory to...To view the full article, register now.
Already a subscriber? Click here to view full article